Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Immunogenicity and safety of high-dose versus double-dose quadrivalent inactivated influenza vaccine in adult kidney transplant recipients: a randomized controlled trial (2023). Local targets link to admitted publications; unresolved targets remain external evidence.
Influenza in solid organ transplant recipients: epidemiology, management, and outcomes
10.1080/14787210.2020.1713098 · 2020 · External reference
Influenza in solid organ transplant recipients: epidemiology, management, and outcomes
10.1080/14787210.2020.1713098 · 2020 · External reference
Comparison of the immunogenicity of a monovalent influenza A/H1N1 2009 vaccine between healthy individuals, patients with chronic renal failure, and immunocompromised populations
10.1016/j.transproceed.2013.11.063 · 2014 · External reference
Comparison of the immunogenicity of a monovalent influenza A/H1N1 2009 vaccine between healthy individuals, patients with chronic renal failure, and immunocompromised populations
10.1016/j.transproceed.2013.11.063 · 2014 · External reference
Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice
10.1111/ctr.13563 · 2019 · External reference
Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice
10.1111/ctr.13563 · 2019 · External reference
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: a randomized controlled trial
10.1016/j.vaccine.2018.08.057 · 2018 · External reference
Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: a randomized controlled trial
10.1016/j.vaccine.2018.08.057 · 2018 · External reference
An open-label randomized controlled parallel-group pilot study comparing the immunogenicity of a Standard-Double-and booster-dose regimens of the 2014 seasonal trivalent inactivated influenza vaccine in kidney transplant recipients
10.1097/tp.0000000000003702 · 2022 · External reference
An open-label randomized controlled parallel-group pilot study comparing the immunogenicity of a Standard-Double-and booster-dose regimens of the 2014 seasonal trivalent inactivated influenza vaccine in kidney transplant recipients
10.1097/tp.0000000000003702 · 2022 · External reference
A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients
10.1093/cid/cix1082 · 2018 · External reference
A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients
10.1093/cid/cix1082 · 2018 · External reference
Unresolved reference
2007 · External reference
Unresolved reference
2007 · External reference
Immunogenicity of high-dose versus MF59-Adjuvanted versus standard influenza vaccine in solid organ transplant recipients: the swiss/spanish trial in solid organ transplantation on prevention of influenza (STOP-FLU trial)
10.1093/cid/ciad477 · 2024 · External reference
Immunogenicity of high-dose versus MF59-Adjuvanted versus standard influenza vaccine in solid organ transplant recipients: the swiss/spanish trial in solid organ transplantation on prevention of influenza (STOP-FLU trial)
10.1093/cid/ciad477 · 2024 · External reference
Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-Infected persons: a single-center, parallel, randomized trial
10.7326/0003-4819-158-1-201301010-00005 · 2013 · External reference
Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-Infected persons: a single-center, parallel, randomized trial
10.7326/0003-4819-158-1-201301010-00005 · 2013 · External reference
Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: a pilot randomized clinical trial
10.1016/j.vaccine.2015.12.037 · 2016 · External reference
Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: a pilot randomized clinical trial
10.1016/j.vaccine.2015.12.037 · 2016 · External reference
The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity
10.1080/21645515.2019.1565269 · 2019 · External reference
The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity
10.1080/21645515.2019.1565269 · 2019 · External reference
Seasonal influenza vaccine in immunocompromised persons
10.1080/21645515.2018.1445446 · 2018 · External reference
Seasonal influenza vaccine in immunocompromised persons
10.1080/21645515.2018.1445446 · 2018 · External reference
An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: a randomized controlled trial (CVIM 4 study)
10.1111/ajt.17151 · 2022 · External reference
An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: a randomized controlled trial (CVIM 4 study)
10.1111/ajt.17151 · 2022 · External reference
Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use—United states, 2010
2010 · External reference
Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use—United states, 2010
2010 · External reference
